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The Community Pharmacy Agreement is a five-year agreement (now in its fifth cycle) that governs
how pharmacies supply medicines listed on the Pharmaceutical Benefits Scheme (PBS). While the
average Australian makes more than 14 visits to a community pharmacy every year, not many know
about how this agreement impacts pharmacy in Australia.
Pharmacies buy medication from wholesalers, sell them to people who bring in prescriptions and are 
reimbursed by the government for drugs listed on the PBS. They’re also paid for the professional
advice they provide when dispensing those medicines.
Patients pay a contribution towards the cost of their medication to the pharmacist, who then claims
from the government the difference between what they paid the wholesaler and the patient
contribution. In the financial year ending June 30 2014, the government spent $9.1 billion on
PBS-listed drugs. Exactly what this money went to was governed by the Community Pharmacy
Agreement.
Getting approval
The agreement is formed between the Pharmaceutical Guild of Australia (PGA) and the
Commonwealth government because of a key clause in the National Health Act 1953. This says any
agreement relating to how the Commonwealth remunerates items on the PBS needs to be made with
the PGA or another pharmacists’ organisation that represents the majority of “approved pharmacists”.
Patients pay a contribution towards the cost of their medication to the pharmacist who then claims the
difference between what they paid and the patient contribution from the government. Gustavo
Gomes/Flickr, CC BY-NC
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Approval requires pharmacists to apply to the Australian Community Pharmacy Authority (ACPA), an
independent statutory authority that considers applications to supply PBS medicines under Section
90 of the Act. As part of assessing applications, the ACPA has to consider the location of the proposed
pharmacy because we need pharmacies to form a distribution network so everyone in the country has
access to PBS-listed drugs.
In Australia, you can only own a pharmacy if you are a qualified pharmacist. So the people
representing the approved “Section 90” pharmacies are pharmacist-owners, and the Pharmaceutical
Guild is their professional organisation.
A brief history
The first Community Pharmacy Agreement (CPA) began in 1991 and its focus was on optimising the
distribution of pharmacy services around the country. At the time, there were concerns that more
pharmacies were located in metropolitan areas while regional and rural Australia went without. The
agreement introduced a new remuneration framework for pharmacies supplying PBS medicines and
created incentives for pharmacies in rural and remote areas.
The CPA was also a response to concerns in government and the pharmacy profession about
Australia’s large pharmacy-to-population ratio (much higher than other Western countries) and the
lack of consistency in various financial drivers across the profession, including for mark-ups and fees
for dispensing PBS medicines.
Under the first CPA, the number of pharmacies in Australia fell from 5,500 to 4,950 by the end of
1995. This included voluntary closures of over 600 pharmacies and more than 60 mergers, and cost
the government more than $50 million.
Each subsequent agreement has helped maintain the principle of equal distribution of pharmacies
across the country through controls placed on the profession via the location rule, which says a
pharmacy may not open within 1.5 kilometres of an existing one.
In Australia, you can only own a pharmacy if you are a qualified pharmacist. Ged Carroll/Flickr, CC BY
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The fifth Community Pharmacy Agreement, which commenced on July 1 2010, also contains
remuneration ($663 million, or less than 5% of the total CPA budget) for clinical services that
enhance patient medication management. These include one-on-one medication reviews, which can
take between 20 and 30 minutes in-store, or up to an hour in the patient’s home.
The current CPA totals $15.4 billion, with the bulk of the funding ($13.8 billion) allocated directly to
individual pharmacies for PBS-related services.
A final part of the puzzle
Another critical part of the CPA is the Community Services Obligation (CSO), which is an
arrangement between the government and pharmaceutical wholesalers. The core of the CPA
arrangement is access to PBS medicines and wholesalers who supply the pharmacies are pivotal
players in the supply chain.
The CPA provides direct financial support ($950 million) to certain pharmaceutical wholesalers for
any additional cost they may incur in providing the full range of PBS medicines. This ensures the full
range is available regardless of pharmacy location and relative cost of supply. It also helps ensure that
low-volume PBS medicines, which are often very high-cost drugs, are delivered to community
pharmacies anywhere in Australia within 24 hours.
Since its inception 25 years ago, the intent of the Community Pharmacy Agreement has been to
ensure all Australians have access to PBS-listed medications, no matter where they live. Australia’s
network of around 5,500 community pharmacies have played a pivotal role in realising this goal.
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